Dudediligence.

Opus Genetics, Inc

IRDNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$611,062

11 notices · 118,831 sh

Dec 2025 to Oct 2026

Reported ·

$16.4M

12 sales · 2 buys · $323,890 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 12 reported sales carry the 10b5-1 box. Together they are 6.94% of the shares on issue.

PLANNED · FORM 144Dec 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-03: Gagnon Robert E., Form 1442026-07-23: Gagnon Robert E., Form 1442026-07-23: Magrath George, Form 1442026-07-23: SCHACHLE JOSEPH K, Form 1442026-07-23: YERXA BENJAMIN R, Form 1442026-04-23: SCHACHLE JOSEPH K, Form 1442026-04-23: YERXA BENJAMIN R, Form 1442026-04-23: Magrath George, Form 1442026-04-23: Gagnon Robert E., Form 1442026-04-23: Jayagopal Ashwath, Form 1442026-03-16: Magrath George, Form 1442025-12-09: Foundation Fighting Blindness Retinal Degeneration Fund, sold2025-12-29: Gallagher Cam, bought2026-03-16: Jayagopal Ashwath, sold2026-03-16: Magrath George, sold2026-03-16: Zaremba Rabourn Amy, sold2026-03-16: SCHACHLE JOSEPH K, sold2026-04-23: Gagnon Robert E., sold2026-04-23: Jayagopal Ashwath, sold2026-04-23: Magrath George, sold2026-04-23: Zaremba Rabourn Amy, sold2026-04-23: SCHACHLE JOSEPH K, sold2026-04-23: YERXA BENJAMIN R, sold2026-05-18: Foundation Fighting Blindness Retinal Degeneration Fund, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-03Gagnon Robert E., Chief Financial Officer$124,600
28,000 shplan 2026-04-30Form 4s on file end Jun 23144 ↗
2026-07-23Gagnon Robert E., Chief Financial Officer$23,738
7,783 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-23Magrath George, Chief Executive Officer$28,899
9,475 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-23SCHACHLE JOSEPH K, Chief Operating Officer$13,653
4,644 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-23YERXA BENJAMIN R, President$22,064
7,429 shno plan dateForm 4s on file end Jun 23144 ↗
2026-04-23SCHACHLE JOSEPH K, Chief Operating Officer$24,519
4,697 shno plan date144 ↗
Form 4, 2026-04-27: sold 4,697 at $5.22 Form 4 ↗
2026-04-23YERXA BENJAMIN R, President$39,121
7,470 shno plan date144 ↗
Form 4, 2026-04-27: sold 7,470 at $5.24 Form 4 ↗
2026-04-23Magrath George, Chief Executive Officer$127,327
9,511 shno plan date144 ↗
Form 4, 2026-04-27: sold 9,511 at $5.22 Form 4 ↗
2026-04-23Gagnon Robert E., Chief Financial Officer$40,658
7,842 shno plan date144 ↗
Form 4, 2026-04-27: sold 7,842 at $5.18 Form 4 ↗
2026-04-23Jayagopal Ashwath, Chief Scientific & Dev. Ofc.$39,156
7,542 shno plan date144 ↗
Form 4, 2026-04-27: sold 7,542 at $5.19 Form 4 ↗
2026-03-16Magrath George, Chief Executive Officer$127,327
24,438 shno plan date144 ↗
Form 4, 2026-03-18: sold 24,438 at $5.21 Form 4 ↗